Last 48 quarters of trend data · Healthcare · Medical - Care Facilities
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
Encompass Health Corporation's quarterly P/E stands at 13.7x, down 20.1% year-over-year — suggesting improving earnings relative to price. EV/EBITDA has compressed 17.4% YoY to 7.7x, reflecting multiple compression or accelerating EBITDA.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 17.69 | 13.66 | 18.56 | 25.61 | 22.06 | 17.11 | 19.57 | 22.79 | 19.15 | 18.77 | 19.40 | 19.99 | 18.81 |
| — | -20.1% | -5.2% | +12.4% | +15.2% | -8.8% | +0.9% | +14.0% | +1.8% | +20.7% | +14.1% | -20.5% | -17.3% | |
| P/S Ratio | 1.64 | 1.53 | 1.75 | 2.20 | 2.15 | 1.78 | 1.68 | 1.83 | 1.68 | 1.60 | 1.36 | 1.41 | 1.44 |
| — | -13.7% | +4.2% | +20.4% | +27.8% | +10.8% | +23.8% | +29.4% | +16.6% | +36.3% | +2.5% | +35.2% | +37.1% | |
| P/B Ratio | 3.06 | 2.89 | 3.30 | 4.08 | 4.06 | 3.52 | 3.32 | 3.62 | 3.46 | 3.51 | 2.95 | 3.11 | 3.33 |
| — | -17.9% | -0.3% | +12.7% | +17.3% | +0.2% | +12.5% | +16.4% | +3.9% | +26.3% | -9.0% | +19.6% | +89.4% | |
| P/FCF | 22.19 | — | 23.19 | 38.81 | 27.65 | 20.60 | 29.49 | 20.50 | 36.16 | 21.23 | — | 24.85 | 19.12 |
| — | — | -21.3% | +89.3% | -23.5% | -3.0% | — | -17.5% | +89.1% | +104.2% | — | — | +113.7% | |
| EV / EBITDA | 8.95 | 7.73 | 9.08 | 11.97 | 11.12 | 9.35 | 9.73 | 10.84 | 9.98 | 10.07 | 4.66 | 4.82 | 4.80 |
| — | -17.4% | -6.6% | +10.4% | +11.5% | -7.1% | +108.7% | +125.0% | +108.0% | +142.6% | -49.7% | -45.4% | -48.0% | |
| EV / EBIT | 11.73 | — | 11.67 | 15.56 | 14.11 | 11.97 | 12.88 | 14.25 | 13.07 | 13.09 | 12.64 | 13.37 | 13.09 |
| — | — | -9.4% | +9.2% | +8.0% | -8.6% | +1.9% | +6.6% | -0.2% | +16.4% | +5.8% | +4.6% | -3.3% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Encompass Health Corporation's operating margin was 14.6% in Q1 2026, down 3.7 pp QoQ and down 3.7 pp YoY. The trailing four-quarter average of 16.8% exceeds the current quarter, suggesting the latest result may reflect seasonal weakness or a one-off headwind. Gross margin expanded 11.7% YoY, indicating pricing power or improving input costs.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 95.7% | 48.4% | 95.8% | 46.9% | 43.0% | 43.3% | 41.7% | 41.3% | 41.7% | 41.5% | 41.1% | 41.0% | 42.0% |
| — | +11.7% | +129.8% | +13.5% | +3.0% | +4.5% | +1.6% | +0.9% | -0.7% | +0.8% | -56.9% | -57.0% | -56.0% | |
| Operating Margin | 17.7% | 14.6% | 18.3% | 16.5% | 17.8% | 18.3% | 16.5% | 15.5% | 16.6% | 15.8% | 35.7% | 35.7% | 36.2% |
| — | -20.2% | +11.0% | +6.5% | +7.3% | +16.4% | -53.7% | -56.6% | -54.2% | -56.5% | +125.8% | +161.8% | +157.0% | |
| Net Margin | 9.5% | 12.3% | 9.5% | 8.6% | 9.7% | 10.4% | 8.6% | 8.0% | 8.8% | 8.5% | 7.0% | 7.1% | 7.7% |
| — | +17.8% | +9.9% | +6.9% | +11.2% | +21.8% | +22.5% | +13.3% | +13.9% | +13.1% | -10.6% | +69.6% | +68.0% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 18.5% | 5.9% | 4.5% | 4.0% | 4.7% | 5.2% | 4.3% | 4.1% | 4.6% | 4.8% | 3.9% | 4.0% | 4.5% |
| — | +11.8% | +4.2% | -2.1% | +2.0% | +9.4% | +11.1% | +2.5% | +1.7% | +4.4% | -21.2% | +89.9% | +135.1% | |
| ROA | 8.3% | 2.7% | 2.1% | 1.9% | 2.1% | 2.3% | 1.9% | 1.7% | 1.8% | 1.8% | 1.5% | 1.4% | 1.6% |
| — | +17.4% | +12.5% | +10.0% | +17.1% | +26.1% | +28.2% | +16.8% | +14.8% | +18.4% | -9.8% | +99.5% | +126.8% | |
| ROIC | 13.9% | 3.7% | 3.6% | 3.2% | 3.5% | 3.6% | 3.2% | 3.0% | 3.1% | 3.0% | 6.6% | 6.6% | 6.9% |
| — | +2.0% | +12.8% | +8.2% | +12.2% | +20.0% | -51.2% | -55.1% | -54.9% | -55.0% | +132.1% | +209.0% | +249.4% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Encompass Health Corporation's Debt/EBITDA ratio is 0.8x, down from 7.3x last quarter — comfortably within a safe range. The current ratio has improved 10.3% YoY to 1.17x, strengthening the short-term liquidity position. Debt/Equity has declined for 12 consecutive quarters, reflecting a deleveraging trend.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.83 | 0.08 | 0.83 | 0.84 | 0.87 | 0.92 | 0.95 | 1.03 | 1.16 | 1.21 | 1.28 | 1.34 | 1.43 |
| — | -91.7% | -13.0% | -18.7% | -25.3% | -24.3% | -25.4% | -23.1% | -18.5% | -10.5% | -20.6% | -20.9% | +2.9% | |
| Debt / EBITDA | 1.97 | 0.81 | 7.34 | 8.16 | 7.92 | 7.81 | 8.75 | 9.74 | 10.21 | 10.51 | 5.70 | 5.88 | 5.86 |
| — | -89.6% | -16.1% | -16.2% | -22.4% | -25.7% | +53.5% | +65.7% | +74.3% | +91.0% | -53.7% | -58.1% | -65.2% | |
| Current Ratio | 1.08 | 1.17 | 1.08 | 1.14 | 1.06 | 1.06 | 1.05 | 1.04 | 1.35 | 1.37 | 1.28 | 1.27 | 1.26 |
| — | +10.3% | +2.7% | +9.7% | -21.4% | -22.1% | -17.8% | -18.3% | +7.4% | +6.2% | +3.0% | +4.9% | +1.8% | |
| Quick Ratio | 1.08 | 1.17 | 1.08 | 1.14 | 1.06 | 1.06 | 1.05 | 1.04 | 1.35 | 1.37 | 1.28 | 1.27 | 1.26 |
| — | +10.3% | +2.7% | +9.7% | -21.4% | -22.1% | -17.8% | -18.3% | +7.4% | +6.2% | +3.0% | +4.9% | +1.8% | |
| Interest Coverage | 8.74 | 7.31 | 9.53 | 8.14 | 8.79 | 8.50 | 7.10 | 6.27 | 6.42 | 6.07 | 5.44 | 5.00 | 5.07 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Deep dive into EHC consensus models and risk factors.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying EHC stock.
Encompass Health Corporation's current P/E is 17.7x. The average P/E over the last 4 quarters is 20.0x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Encompass Health Corporation's current operating margin is 17.7%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Encompass Health Corporation's business trajectory between earnings reports.